You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pharmacodynamic Biomarker

Showing 1 - 25 of 5,881
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allergic Asthma Trial in Kansas City (Levocetirizine DiHCl, Placebo)

Recruiting
  • Allergic Asthma
  • Levocetirizine Dihydrochloride
  • Placebo
  • Kansas City, Missouri
    Children's Mercy Hospital
Apr 26, 2022

Eating Disorders, Binge Eating, Purging (Eating Disorders) Trial in Kansas City (Naltrexone, Placebo)

Not yet recruiting
  • Eating Disorders
  • +4 more
  • Kansas City, Missouri
    Children's Mercy Research Institute
Aug 18, 2022

Idiopathic Pulmonary Fibrosis Trial in London (LTI-03, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • London, United Kingdom
    Study Site
Jul 18, 2023

Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (other, biological, procedure)

Active, not recruiting
Has Results
  • Recurrent Glioblastoma
  • Recurrent Gliosarcoma
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 19, 2022

CDKN2A-p16 Positive, Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Stage I Oropharyngeal Squamous Cell

Recruiting
  • CDKN2A-p16 Positive
  • +5 more
  • Tucson, Arizona
    The University of Arizona Medical Center-University Campus
Mar 7, 2022

Adult Solid Tumor Trial in Chicago (Carboplatin, Laboratory Biomarker Analysis, Paclitaxel)

Active, not recruiting
  • Adult Solid Neoplasm
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 25, 2023

Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Duarte, South

Withdrawn
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Duarte, California
  • +2 more
Feb 21, 2022

Alzheimer, Parkinson Disease Trial in United States (Posiphen)

Completed
  • Alzheimer Disease
  • Parkinson Disease
  • Stamford, Connecticut
  • +12 more
May 5, 2022

Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Los Angeles, California
  • +11 more
Jul 1, 2022

Renal Cell Carcinoma Trial in Philadelphia (drug, genetic, other, procedure)

Terminated
Has Results
  • Renal Cell Carcinoma
  • Brivanib alaninate
  • +5 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 18, 2021

Cushing Syndrome, Cushing Disease, Ectopic ACTH Syndrome Trial run by the Crinetics Pharmaceuticals Inc. (CRN04894)

Recruiting
  • Cushing Syndrome
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health (NIH) - National Institute of Diab
Mar 27, 2023

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Seattle (Abiraterone

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Abiraterone Acetate
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 22, 2021

Celiac Disease Trial in Saint Paul, Columbus (Cohort 1 in Part A, Cohort 2 in Part A, Cohort 3 in Part A)

Recruiting
  • Celiac Disease
  • Cohort 1 in Part A
  • +6 more
  • Saint Paul, Minnesota
  • +1 more
Jan 19, 2023

Breast Cancer Trial in Vancouver, Toronto (drug, other, procedure)

Completed
  • Breast Cancer
  • sunitinib malate
  • +5 more
  • Vancouver, British Columbia, Canada
  • +1 more
Sep 16, 2020

Healthy Volunteers, Tauopathies, Alzheimer Trial in Long Beach (APNmAb005, Placebo)

Recruiting
  • Healthy Volunteers
  • +2 more
  • Long Beach, California
    Collaborative Neuroscience Research, LLC., 2600 Redondo Ave.
Jun 1, 2022

Prostate Cancer Trial in Cambridge (Olaparib, Degarelix)

Completed
  • Prostate Cancer
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital, Cambridge University Hospitals Foundatio
Aug 28, 2019

Asthma Trial in Hefei (MG-ZG122 Humanized Monoclonal Antibody Injection, Placebo)

Not yet recruiting
  • Asthma
  • MG-ZG122 Humanized Monoclonal Antibody Injection
  • Placebo
  • Hefei, Anhui, China
    The Second Affiliated Hospital of Anhui Medical University
Dec 13, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • +8 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +7 more
  • (no location specified)
Jul 15, 2023

Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

Recruiting
  • Metastatic or Locally Advanced Unresectable Solid Tumors
  • Houston, Texas
  • +4 more
Jul 7, 2022

Crohn Disease Trial in United States (RoadMAB, Infliximab)

Not yet recruiting
  • Crohn Disease
  • Los Angeles, California
  • +9 more
Dec 19, 2022

Advanced Solid Tumor Trial in Dallas (TCRT-ESO-A2)

Withdrawn
  • Advanced Solid Tumor
  • TCRT-ESO-A2
  • (no location specified)
Aug 31, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Grand Rapids, Michigan
  • +2 more
Jul 18, 2022

TRACK-TBI Longitudinal Biomarker Study

Enrolling by invitation
  • Traumatic Brain Injury
  • Telephone Outcome Assessment
  • +3 more
  • San Francisco, California
  • +10 more
May 31, 2022

Prostate Cancer Trial in Cambridge (AZD2014)

Completed
  • Prostate Cancer
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Jul 15, 2019

Parkinson's Disease Trial in Saint Louis (Levodopa)

Completed
  • Parkinson's Disease
  • Saint Louis, Missouri
    Washington University School of Medicine, Movement Disorders Cen
Oct 12, 2022